AbbVie
在场
是其中之一......
- Forbes Global 2000 (#89);
- Fortune 500 (#77);
- Global Fortune 500 (#259);
- Russell 3000;
- S&P 500;
- TOB Iconic 10,000.
AbbVie 是一家在股票代码 ABBV (US) 下上市的公司。
AbbVie 在 23 个国家有直接业务。AbbVie 拥有 34家子公司，其中包括 AbbVie APAC、AbbVie Australia 和 AbbVie Belgium。
他们在：
涉及AbbVie的并购和融资。
- AbbVie 已收购 Cerevel Therapeutics (公布2024八月5号).
- AbbVie 已收购 Landos Biopharma (公布2024五月25号).
- AbbVie has announced the acquisition of ImmunoGen (公布2023十一月30号).
高管
查看带有其 269 名主要高管的组织结构图
AbbVie 搜索最多的简介
- Robert Michael, Chief Executive Officer and Director
- Richard Gonzalez, Executive Chairman of the Board
- Roxanne Austin, Lead Independent Director
高管在AbbVie变化
- Thomas Hudson, Senior Vice President, R&D and Chief Scientific Officer, 正在办理退休 (新闻发布的2024七月10号).
- Roxanne Austin 曾任 Director, 将于 20247月1 升职为 Lead Independent Director (新闻发布的2024六月21号).
创建提醒
跟踪 AbbVie 的高管变动
药店
AbbVie 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
AbbVie 的最新新闻稿
- AbbVie Completes Acquisition of Aliada Therapeutics
- AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients
- Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
- AbbVie to Present at Citi's 2024 Global Healthcare Conference
- AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer
- Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan Aesthetics Products
- AbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia
- AbbVie Awards 20 Individuals Living With Migraine To Support Career Aspirations
- Allergan Aesthetics Celebrates Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day
- AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics
- View more press releases Close
通过电子邮件
